YouTube Bans Anti-Vaccine Misinformation
The new set of policies will cover not just the Covid-19 vaccines or long-approved vaccines against diseases like measles and hepatitis B, but also general claims about vaccines, YouTube said. (Source: NYT Health)
Source: NYT Health - September 29, 2021 Category: Consumer Health News Authors: Davey Alba Tags: YouTube.com Vaccination and Immunization Rumors and Misinformation Coronavirus (2019-nCoV) Kennedy, Robert F Jr Mercola, Joseph M (1954- ) Children ' s Health Defense Social Media Source Type: news
NIAID Scientists Find a Key to Hepatitis C Entry into Cells
Understanding Structure of HCV Proteins Could Aid in Vaccine Development. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 21, 2021 Category: American Health Source Type: news
Janssen Demonstrates Commitment to Advancing Science and Innovation in the Treatment of Solid Tumors at ESMO Annual Congress
September 8, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than ten data presentations from its lung cancer, bladder cancer and prostate cancer portfolio and pipeline will be featured during the European Society for Medical Oncology (ESMO) Annual Congress 2021 virtual meeting, September 16–21. Further details about these data and the science Janssen is advancing will be made available throughout ESMO via the Janssen Oncology Virtual Newsroom.“With a diverse oncology portfolio and pipeline spanning bladder cancer, lung cancer and prostate cancer, Janssen...
Source: Johnson and Johnson - September 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Africa: Messenger RNA - How It Works in Nature and in Making Vaccines
[The Conversation Africa] Vaccines have long been an integral part of public health programmes around the world, reducing the spread and severity of infectious diseases. The success of immunisation strategies to protect children from diseases like polio, hepatitis B, and measles, and adults from influenza and pneumococcal disease, can be seen globally. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 7, 2021 Category: African Health Source Type: news
Estimating cost effectiveness of hepatitis B vaccination in US adults
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2021 Category: Drugs & Pharmacology Source Type: news
Fauci:'Good Idea' to Implement School Vaccine Mandates Fauci:'Good Idea' to Implement School Vaccine Mandates
"We ' ve done this for decades and decades, requiring polio, measles, mumps, rubella, hepatitis," he added."So this would not be something new, requiring vaccinations for children to come to school."WebMD Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - August 30, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news
Vaccine Access Negotiations to Resume as New Variants Spread
Vaccine access negotiations are at critical juncture. While many countries support the intellectual property rights waiver, including the European parliament the European Union does not. Credit: PAHO/Karen GonzálezBy Lyndal RowlandsMelbourne, Australia , Aug 30 2021 (IPS) A committee that has spent almost a year negotiating the terms of a temporary intellectual property waiver for Covid-19 medicines will reconvene in September after pausing for the European Summer.
As new variants spread rapidly around the world, the deadlock in the World Trade Organization Trade-Related Aspects of Intellectual Property Rights (TRIPS) Co...
Source: IPS Inter Press Service - Health - August 30, 2021 Category: International Medicine & Public Health Authors: Lyndal Rowlands Tags: COVID-19 Development & Aid Economy & Trade Featured Global Headlines Health Humanitarian Emergencies TerraViva United Nations COVAX COVID-19 vaccines TRIPS. WTO Source Type: news
Progress Toward Hepatitis B Control - World Health Organization European Region, 2016-2019
This report describes progress toward hepatitis B control in the World Health Organization European Region. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - July 29, 2021 Category: American Health Tags: Hepatitis B Hepatitis B Vaccination MMWR Morbidity & Mortality Weekly Report Source Type: news
Cameroon: 13th World Hepatitis Day - Free Screening Ongoing in Yaounde
[Cameroon Tribune] The exercise, taking place at the International Vaccination Centre ends on Friday, July 30, 2021. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 28, 2021 Category: African Health Source Type: news
Vaccine sales help GSK beat forecasts
Demand for jabs for meningitis, diphtheria and hepatitis recovers after pandemic disruption (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 28, 2021 Category: Pharmaceuticals Source Type: news
CDC: Advisory Committee on Immunization Practices (ACIP)
The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) is hosting a virtual meeting on September 29-30, 2021. The agenda will include discussions on cholera vaccine, hepatitis vaccines, herpes zoster vaccines, orthopoxvirus vaccine, pneumococcal vaccine, and tickborne encephalitis vaccine. Includes information on how to submit public comments or request permission to make a public comment during the meeting. Registration is not required and the meeting is open to the public, available online via a live webcast. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - July 26, 2021 Category: Rural Health Source Type: news
European Duplicity Undermines Anti-Pandemic Efforts
By Anis Chowdhury and Jomo Kwame SundaramSYDNEY and KUALA LUMPUR, Jul 20 2021 (IPS) Despite facing the world’s worst pandemic of the last century, rich countries in the World Trade Organization (WTO) have blocked efforts to enable more affordable access to the means to fight the pandemic.
Everyone knows access for all to the means for testing, treatment and prevention – including diagnostic tests, therapeutic medicines, personal protective equipment and vaccines – is crucial.
Anis ChowdhuryEuropean deceit
In October 2020, South Africa and India requested the WTO to temporarily suspend relevant provisions of its Agre...
Source: IPS Inter Press Service - Health - July 20, 2021 Category: International Medicine & Public Health Authors: Anis Chowdhury and Jomo Kwame Sundaram Tags: Aid Development & Aid Economy & Trade Global Headlines Health Human Rights Humanitarian Emergencies TerraViva United Nations Jomo Kwame Sundaram & Anis Chowdhury Source Type: news
New COVID-19 vaccine candidate provides effective option for low- to mid-income countries
(Emory Health Sciences) Combining yeast-expression technology and a novel adjuvant formulation to produce a COVID-19 vaccine candidate is effective against SARS-COV-2 and promises to be easy to produce at large scale and cost-effective, important aspects for vaccinating people worldwide, especially in low- to middle-income countries. Results from the study, which applied lessons learned from the hepatitis b vaccine platform technology, are published online today in Science Immunology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 15, 2021 Category: International Medicine & Public Health Source Type: news
Hepatitis C vaccine could be rolled out within five years, says Nobel Prize winner who discovered virus
(European Society of Clinical Microbiology and Infectious Diseases) A vaccine to protect against infection with hepatitis C could be in use within 5 years, says Professor Sir Michael Houghton, who won the Nobel Prize for Medicine and Physiology along with three other scientists for discovering the hepatitis C virus (HCV) in 1989. Sir Michael will discuss the development of a vaccine in a special presentation at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 11, 2021 Category: International Medicine & Public Health Source Type: news
Introducing birth-dose hepatitis B vaccination would be cost effective in Burkina Faso
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - July 1, 2021 Category: Drugs & Pharmacology Source Type: news
